CorMedix Inc.
CRMDNasdaq
$8.42
↑ +1.6%Jul 17 close · end-of-day
Price
1Y↓ -24.3%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$782.9M
Enterprise Value
$604.8M
P/E
3.9
P/S
2.0
P/B
1.8
EV/EBITDA
3.0
PEG
—
FCF Yield
24.9%
Dividend Yield
—
Revenue (TTM)
$400.1M
Net Income (TTM)
$181.0M
Free Cash Flow (TTM)
$194.7M
Gross Margin
85.8%
Operating Margin
48.4%
Net Margin
45.3%
ROE
41.4%
ROIC
73.2%
Debt / Equity
—
Net Cash
$178.1M
Return 1Y
-23.9%
Company profile
CorMedix Inc. focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings.
- CEO
- Joseph Todisco
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 30
- Headquarters
- New Jersey
- Website
- cormedix.com
Management & directors
- Masson ElizabethChief Operating Officer
- Todisco JosephChief Executive Officer
- Zelnick Kaufman BethChief Legal Officer
- Blum SusanChief Financial Officer
- Seckler Michael DavidChief Commercial Officer
Roles derived from SEC Form 4 filings.
Earnings
CRMD Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$127.4M↑ +226.1%
Diluted EPS$0.43↑ +43.3%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $239,231.00 | $190,936.00 | $65,408.00 | — | $43.5M | $311.7M |
| Gross profit | $34,385.00 | $41,998.00 | $61,674.00 | — | $40.3M | $275.7M |
| Operating income | -$27.2M | -$29.4M | -$30.6M | -$49.0M | -$22.4M | $150.1M |
| Net income | -$22.0M | -$28.2M | -$29.7M | -$46.3M | -$17.9M | $163.1M |
| Diluted EPS | — | -$0.75 | -$0.74 | -$0.91 | -$0.30 | $2.04 |
| Operating cash flow | -$22.0M | -$21.2M | -$24.4M | -$38.4M | -$50.6M | $175.0M |
| Free cash flow | -$22.1M | -$22.6M | -$24.6M | -$38.7M | -$50.7M | $172.8M |
| Gross margin | 14.4% | 22.0% | 94.3% | — | 92.7% | 88.5% |
| Operating margin | -11378.4% | -15417.5% | -46819.9% | — | -51.4% | 48.2% |
| Net margin | -9207.7% | -14774.7% | -45409.9% | — | -41.2% | 52.3% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $806,119.00 | $11.5M | — | $39.1M | $39.7M | $104.3M | $128.6M | $127.4M |
| Gross profit | $296,280.00 | $10.8M | $30.0M | $37.5M | $37.9M | $93.1M | $107.3M | $105.1M |
| Operating income | -$15.3M | -$3.3M | $12.9M | $20.1M | $19.5M | $51.3M | $59.1M | $63.7M |
| Net income | -$14.2M | -$2.8M | $13.5M | $20.6M | $19.8M | $108.6M | $14.0M | $38.6M |
| Diluted EPS | -$0.25 | -$0.05 | $0.25 | $0.30 | $0.28 | $1.26 | $0.20 | $0.43 |
| Operating cash flow | -$14.0M | -$13.6M | -$5.6M | $19.7M | $30.0M | $30.9M | $94.5M | $42.4M |
| Free cash flow | -$14.1M | -$13.7M | -$5.6M | $19.7M | $30.0M | $30.4M | $92.7M | $41.7M |
| Gross margin | 36.8% | 94.0% | — | 95.9% | 95.3% | 89.3% | 83.4% | 82.5% |
| Operating margin | -1898.1% | -28.7% | — | 51.5% | 49.2% | 49.2% | 46.0% | 50.0% |
| Net margin | -1755.5% | -24.2% | — | 52.8% | 49.9% | 104.1% | 10.9% | 30.3% |
Company news
Jul 9, 2026
Jun 30, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-02-04 | Zelnick Kaufman Beth· Chief Legal Officer | Award | 36,006 | $0.00 | $0.00 | filing |
| 2026-02-04 | Todisco Joseph· Chief Executive Officer | Award | 77,156 | $0.00 | $0.00 | filing |
| 2026-02-04 | Masson Elizabeth· Chief Operating Officer | Award | 36,006 | $0.00 | $0.00 | filing |
| 2026-01-26 | Lefkowitz Steven W | Award | 30,453 | $0.00 | $0.00 | filing |
| 2026-01-26 | Duncan Gregory Scott | Award | 30,453 | $0.00 | $0.00 | filing |
| 2026-01-26 | Stewart Robert A | Award | 30,453 | $0.00 | $0.00 | filing |
| 2026-01-26 | DUNTON ALAN W | Award | 30,453 | $0.00 | $0.00 | filing |
| 2026-01-26 | Kaplan Myron | Award | 30,453 | $0.00 | $0.00 | filing |
| 2026-01-26 | Dillione Janet | Award | 30,453 | $0.00 | $0.00 | filing |
| 2026-01-23 | Todisco Joseph· Chief Executive Officer | Tax withholding | 27,306 | $7.27 | $198,514.62 | filing |
| 2026-01-23 | Masson Elizabeth· Chief Operating Officer | Tax withholding | 10,778 | $7.27 | $78,356.06 | filing |
| 2026-01-23 | Blum Susan· Chief Financial Officer | Tax withholding | 9,767 | $7.27 | $71,006.09 | filing |
| 2026-01-23 | Zelnick Kaufman Beth· Chief Legal Officer | Tax withholding | 8,803 | $7.27 | $63,997.81 | filing |
| 2026-01-23 | Masson Elizabeth· Chief Operating Officer | Award | 93,010 | $0.00 | $0.00 | filing |
| 2026-01-23 | Blum Susan· Chief Financial Officer | Award | 72,820 | $0.00 | $0.00 | filing |
| 2026-01-23 | Zelnick Kaufman Beth· Chief Legal Officer | Award | 72,820 | $0.00 | $0.00 | filing |
| 2026-01-23 | Todisco Joseph· Chief Executive Officer | Award | 225,900 | $0.00 | $0.00 | filing |
| 2026-01-21 | Dillione Janet | Sale | 10,000 | $6.88 | $68,800.00 | filing |
| 2026-01-17 | Todisco Joseph· Chief Executive Officer | Tax withholding | 22,665 | $6.78 | $153,668.70 | filing |
| 2026-01-16 | Todisco Joseph· Chief Executive Officer | Option exercise | 29,585 | $3.38 | $99,997.30 | filing |
| 2026-01-12 | Todisco Joseph· Chief Executive Officer | Tax withholding | 17,417 | $7.15 | $124,531.55 | filing |
| 2026-01-12 | Lefkowitz Steven W | Option exercise | 15,000 | $5.63 | $84,450.00 | filing |
| 2026-01-12 | Masson Elizabeth· Chief Operating Officer | Tax withholding | 5,794 | $7.15 | $41,427.10 | filing |
| 2026-01-08 | Seckler Michael David· Chief Commercial Officer | Award | 133,156 | $0.00 | $0.00 | filing |
| 2026-01-02 | Zelnick Kaufman Beth· Chief Legal Officer | Tax withholding | 11,333 | $12.16 | $137,809.28 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.